Commerce Bank’s ADC Therapeutics ADCT Stock Holding History

Commerce Bank’s Portfolio ADCT Stock Details ADCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$288K	Buy	+235,849	New	+$276K	﹤0.01%	1160

Other funds holding ADCT

ACM

AIGH Capital Management Baltimore, Maryland $992M AUM 516.32% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Panagora Asset Management Boston, Massachusetts $33.2B AUM 43.67% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $294B AUM 47.59% 1-Year Est. Return

Sanibel Captiva Trust Company Sanibel, Florida $4.04B AUM 26.09% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return

Commerce Bank's ADCT Position: Q3 2026 in Review

Commerce Bank opened a new position in ADC Therapeutics (ADCT) in Q3 2026: 235,849 shares worth $288K. The stake represents ﹤0.01% of the portfolio and ranks #1160 among its holdings.

55 funds tracked by Wall St. Rank hold ADCT as of Q3 2026.

Commerce Bank held 235,849 shares of ADC Therapeutics worth $288K as of Q3 2026.
ADC Therapeutics was a new Commerce Bank position in Q3 2026.
ADC Therapeutics made up ﹤0.01% of Commerce Bank's portfolio in Q3 2026, its #1160 holding.
55 funds tracked by Wall St. Rank held ADC Therapeutics as of Q3 2026.

Based on Commerce Bank's 13F filing for Q3 2026, filed 12 Nov 2026.